Sort
8,912 grants matching “sars cov 2”
Molecular Mechanisms of SARS-CoV-2 Infection and Therapeutic Targets
$24,842Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Evaluation of SARS-CoV 2'O Methyltransferase Mutants
$24,805Vineet D Menachery · Univ Of North Carolina Chapel Hill · F32 · FY2015 · AI
COVID-19 - Vet-Lirn Network Capacity Building for SARS-CoV-2: -80 degree freezer andNanodrop
$24,603Leyi Wang · University Of Illinois At Urbana-Champaign · U18 · FY2021 · FD
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex
$24,414Delisa Fairweather · Mayo Clinic Jacksonville · R01 · FY2024 · HL
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex
$24,414Delisa Fairweather · Mayo Clinic Jacksonville · R01 · FY2023 · HL
Automated Nucleic Acid Extraction and Purification System to Build Vet-LIRN Testing Capacity
$24,289Stephen Douglas Cole · University Of Pennsylvania · U18 · FY2023 · FD
Software for sequencing human antibody proteins from polyclonal immune responses
$23,935Anand Patel · Digital Proteomics Llc · R44 · FY2021 · GM
Anticytokine Autoantibodies in COVID-19
$23,911Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Structural Dynamics of Translation
$23,636Dmitri Ermolenko · University Of Rochester · R35 · FY2023 · GM
Investigating MERS-CoV NS4b as a modulator of the host antiviral response in the nucleus
$23,614Stephen Goldstein · University Of Pennsylvania · F31 · FY2018 · AI
Mechanism of Inhibition of Entry Inhibitors against SARS-CoVs
$23,607Di S Xia · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
SARS-CoV2 Immunity and Cell Biology
$23,208Jonathan W Yewdell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Longitudinal mucosal immune response to SARS-CoV-2 starting prior to infection
$22,888Alexander Viloria Winnett · California Institute Of Technology · F30 · FY2024 · AI
Development of COVID-19 cell entry inhibitors
$22,698Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Investigation of the therapeutic potential of oxysterols in SARS-CoV-2 infection
$22,573Michael B Fessler · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Identification of immunological predictors of COVID-19 clinical outcomes
$22,511Andrea Lisco · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
A new therapeutic approach against kidney damage in LN and COVID-19
$22,422Veronica Villanueva · Rush University Medical Center · F31 · FY2023 · DK
Novel SARS-CoV-2 vaccine candidates: Live, recombinant Leishmania
$22,137David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Autonomic Functions in Post-Acute SARS-CoV-2 (PASC)
$22,072David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Development of neutralizing nanobodies against SARS-CoV-2
$22,016Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mitigating COVID-19 transmission in U.S. jails
$21,416Kyle Jeanne Popovich · Rush University Medical Center · R01 · FY2022 · AI
RAPID: Collaborative Research: Bat goblet cells as immuno-hotspots for infection of coronavirus
$21,310Angelique P Corthals · Cuny John Jay College Of Criminal Justice · · FY2020 · BIO
RAPID: Collaborative Research: Immunological adaptations in bats to moderate the effect of coronavirus infection
$21,310Angelique P Corthals · Cuny John Jay College Of Criminal Justice · · FY2020 · BIO
Development of Cell-based Assays to Identify SARS-CoV-2 Protease Inhibitor
$21,300Wei-Shau Hu · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
$21,300Terry L. Sheppard · Keystone Symposia · R13 · FY2023 · HL